Target intelligence / Profile preview

MicroRNA 5681a (miR-5681a)

Target
miR-5681a
Molecular classification
microRNA, Non-coding RNA, Small RNA
01

Overview

MicroRNA 5681a (miR-5681a, also known as hsa-mir-5681a or MIR5681A) is a small, endogenous non-coding RNA molecule belonging to the microRNA family. MicroRNAs are single-stranded RNAs, typically 21–23 nucleotides long, that regulate gene expression post-transcriptionally by binding to target messenger RNAs (mRNAs). This interaction generally leads to mRNA destabilization or inhibition of translation, thereby reducing protein output. While the biological and clinical functions of many human microRNAs have been characterized, the specific functions of miR-5681a are less well defined. However, expression of miR-5681a has been found to be associated with estrogen receptor-positive breast cancers, suggesting a role in cancer biology and possibly serving as a subtype-specific biomarker[3]. No drugs or targeted therapies are currently known to act directly through miR-5681a, and its broader physiological and disease roles, as well as the consequences of modulating its activity, remain a subject for future research.

Other names
hsa-mir-5681aMIR5681AmiR-5681a
02

Mechanism of action

Regulation of gene expression through base-pairing with target mRNAs leading to mRNA degradation or translational repression[1][2][4][6]

03

Biological functions

Post-transcriptional gene silencingRegulation of mRNA stabilityInhibition of protein translationCell differentiationPotential involvement in cell cycle regulation
04

Disease associations

Cancer (notably implicated in breast cancer, particularly in estrogen receptor-positive tumors[3])
05

Safety considerations

As an endogenous microRNA, therapeutic targeting could face challenges such as specificity, delivery, and potential off-target effects common to all miRNA-based interventionssafety profiles for modulating miR-5681a specifically have not been established
06

Biomarkers

Potential biomarker for molecular subtyping in breast cancer (associated with ER-positive breast tumors[3])

Beyond the preview

Go deeper on MicroRNA 5681a (miR-5681a).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 5681a (miR-5681a).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call